What it is5-HT1B/1D agonist causing cranial vasoconstriction; acute migraine and cluster headache.
Why this oneIts subcutaneous form has the fastest onset among triptans, useful when vomiting precludes oral treatment.
What limits itCoronary vasospasm makes it unsuitable in ischemic heart disease or uncontrolled hypertension; overuse causes rebound headache.
FDA-approved for
Off-label
FDA label
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
| Acute migraine (with or without aura) | Adults | 25-100 mg PRN single dose | 50-100 mg PRN single dose | 200 mg/24h |
| Acute migraine, mild-moderate hepatic impairment | Adults | ≤50 mg PRN single dose | ≤50 mg PRN single dose | 50 mg single dose |
Renal Undefined
Hepatic Mild-moderate: max single dose 50 mg; severe: contraindicated
Max 200 mg per 24 hours; safety of treating >4 headaches/30 days not established
Instructions
- Second dose only if partial response to first; separate doses by ≥2 hours
- After Imitrex injection: additional tablets up to 100 mg/day, ≥2 h between doses
Contraindications
- MAOIs (concurrently or within 14 days)
- Ischemic coronary artery disease or coronary vasospasm (incl. Prinzmetal's angina)
- Wolff-Parkinson-White syndrome / arrhythmias with accessory conduction pathways
- History of stroke/TIA, or hemiplegic or basilar migraine
- Peripheral vascular disease; ischemic bowel disease
- Uncontrolled hypertension
- Recent (within 24 h) ergotamine/ergot-type drug or another 5-HT1 agonist
- Current or recent (within 2 weeks) MAO-A inhibitor use
- Severe hepatic impairment
Cautions
- Myocardial ischemia/infarction and Prinzmetal's angina
- Arrhythmias; chest/throat/neck/jaw tightness
- Cerebral/subarachnoid hemorrhage and stroke
- GI and peripheral vasospastic ischemia
- Medication overuse headache; serotonin syndrome; BP increase; seizures
Adverse reactions
- Paresthesia
- Warm/cold sensation
- Chest pain/tightness/pressure
- Neck/throat/jaw pain/tightness
- Malaise/fatigue
Pregnancy Registry/epidemiologic data have not detected increased birth defects; animal data show embryolethality/fetal abnormalities
Lactation Present in human milk; minimize infant exposure; transient breast pain reported
Principal riskCoronary vasospasm; contraindicated in ischemic heart disease
Cost, est. cash$10–$300/month
Generic entry2016
Classes and tags
Clinical profile
Therapeutic safety burden1 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4
Legacy pregnancy categoryC
Defining liabilityAgent-specific vascular, serotonergic or hepatic risks; acute overdose is usually limited outside ergot or cardiovascular agents.
Mechanism of action: Sumatriptan ballicule
Open Sumatriptan in the interactive console ↗
Memory aids: mascots and interaction avatars
“Sumo tripped In my tracks”
Box
Open Sumatriptan in the interactive console ↗